At close: December 13 at 3:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
15,439.3270
16,145.2710
10,604.4280
7,197.8000
5,565.8460
Operating Income
-15,439.3270
-16,145.2710
-10,604.4280
-7,197.8000
-5,565.8460
Net Non Operating Interest Income Expense
-1.3090
-9.1650
-396.4830
-2,805.8560
-662.9990
Other Income Expense
-2,220.0190
-2,135.2890
-3,800.8560
-225.3150
-1,597.1630
Pretax Income
-17,660.6550
-18,289.7250
-14,801.7670
-10,228.9710
-7,826.0080
Net Income Common Stockholders
-17,660.6550
-18,289.7250
-14,801.7670
-10,228.9710
-9,297.8720
Diluted NI Available to Com Stockholders
-17,660.6550
-18,289.7250
-14,801.7670
-10,228.9710
-9,297.8720
Basic EPS
-2.77
-11.00
-28.79
-26.01
-15.78
Diluted EPS
-2.77
-11.00
-28.79
-26.01
-15.78
Basic Average Shares
5,030.0680
1,662.7950
514.2160
392.1170
589.1980
Diluted Average Shares
5,030.0680
1,662.7950
514.2160
392.1170
589.1980
Total Operating Income as Reported
-15,439.3270
-16,145.2710
-10,604.4280
-7,197.8000
-5,565.8460
Total Expenses
15,439.3270
16,145.2710
10,604.4280
7,197.8000
5,565.8460
Net Income from Continuing & Discontinued Operation
-17,660.6550
-18,289.7250
-14,801.7670
-10,228.9710
-7,826.0080
Normalized Income
-17,440.6430
-18,244.1400
-16,676.4210
-10,006.0860
-6,228.8450
Interest Expense
1.3090
9.1650
5.2370
2,805.8560
609.4580
Net Interest Income
-1.3090
-9.1650
-396.4830
-2,805.8560
-662.9990
EBIT
-17,659.3460
-18,280.5600
-14,796.5300
-7,423.1150
-7,216.5500
EBITDA
-17,659.3460
-18,280.5600
-14,796.5300
-7,423.1150
-7,216.5500
Net Income from Continuing Operation Net Minority Interest
-17,660.6550
-18,289.7250
-14,801.7670
-10,228.9710
-7,826.0080
Total Unusual Items Excluding Goodwill
-220.0120
-45.5850
1,874.6540
-222.8850
-1,597.1630
Total Unusual Items
-220.0120
-45.5850
1,874.6540
-222.8850
-1,597.1630
Normalized EBITDA
-17,439.3340
-18,234.9750
-16,671.1840
-7,200.2300
-5,619.3870
12/31/2020 - 8/26/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SPRC SciSparc Ltd.
0.2712
+6.35%
BDRX Biodexa Pharmaceuticals Plc
4.2000
-6.67%
ZVSA ZyVersa Therapeutics, Inc.
1.0502
-1.85%
CDIO Cardio Diagnostics Holdings, Inc.
1.2600
+5.00%
CMND Clearmind Medicine Inc.
1.4733
+1.61%
QNRX Quoin Pharmaceuticals, Ltd.
0.6620
-7.67%
VRAX Virax Biolabs Group Limited
1.5700
-2.48%
NKGN NKGen Biotech, Inc.
0.4998
+1.01%
CDIOW Cardio Diagnostics Holdings, Inc.
0.1050
+11.58%
INAB IN8bio, Inc.
0.2848
-2.00%